go back

Kansas rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $630,957 · 10th–90th $501,187–$2,454,7090%10%20%10th90th$630,957Professionalmedian $562,341 · 10th–90th $524,807–$645,6540%50%10th90th$562,341$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$630,957.34 / $1,230,268.77 / $2,454,708.92
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $575,439.94 / $645,654.23
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$501,187.23 / $501,187.23 / $524,807.46
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $524,807.46
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $562,341.33 / $741,310.24
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $691,830.97